Weight loss jabs like semaglutide and tirzepatide with brands like Ozempic and Mounjaro can significantly curb appetite and ...

Doctors are learning more about the wider effects of the injections, from lowering blood pressure to helping people quit ...

Accounting for mortality as competing risk, the Afib burden trended numerically in favor of the GLP-1 RA group (HR 0.85, 95% ...

In this video at Obesity Medicine 2025, Harold E. Bays, MD, FOMA, FTOS, FACC, FASPC, FNLA, discusses highlights from his talk ...

Expanding Medicare coverage for glucagon-like peptide 1 (GLP-1) receptor agonists could significantly reduce obesity-related ...

Press secretary Karoline Leavitt addressed the Ozempic rumors and insisted that Donald Trump has had no medication in his ...

The pecking order of the obesity drug market is shifting. Eli Lilly , the $815 billion maker of blockbuster weight-loss drugs ...

A common diabetes drug can reduce the pain of people with knee osteoarthritis and overweight or obesity, possibly delaying the need for knee replacements, Monash University-led research has found.

I lost 47 pounds and eliminated three daily medications. This isn’t just my victory—it shows the life-changing potential of modern anti-obesity medications (AOMs). Yet Medicare denies these treatments ...

The benefits consultant Mercer has said that 44% of U.S. companies with 500 or more employees covered obesity drugs last year. Medicare does pay for drugs like Wegovy for patients who have heart ...

A new expert review endorses GLP-1 RAs and other medications for sustainable weight loss in children with obesity and MASLD.

I spent over seven hours in the car driving one way to my most recent doctor’s appointment. For many Americans, this may be shocking, but for those of us ...